
By Peter Nurse
Investing.com -- Stocks in focus in premarket trade on Monday, April 24th. Please refresh for updates.
Bed Bath & Beyond (NASDAQ:BBBY) stock slumped over 35% after the embattled home goods retailer filed for bankruptcy protection, following years of underperformance.
Coca-Cola (NYSE:KO) stock rose 1.4% after the soft drinks giant beat expectations for quarterly revenue, as demand for its produce remained resilient in the face of multiple price increases.
Philips (NYSE:PHG) ADRs climbed 13.2% after the Dutch health technology company reported much better than expected first quarter results and said it had set aside around $630 million related to lawsuits over its recall of respiratory devices.
Credit Suisse (NYSE:CS) ADRs rose 1.9% after the Swiss lender, in the process of being acquired by rival UBS (NYSE:UBS), up 1.6%, shelved plans to purchase Michael Klein’s investment firm following $68 billion of outflows last quarter.
PPG Industries (NYSE:PPG) stock rose 1.8% after JPMorgan upgraded its stance on the industrial coatings supplier to ‘overweight’ from ‘neutral’ following last week’s strong quarterly earnings and upbeat full-year guidance.
Comcast (NASDAQ:CMCSA) stock fell 0.2% after the weekend departure of Jeff Shell, the CEO of unit NBCUniversal, following a complaint of an inappropriate relationship with a woman in the company.
First Solar (NASDAQ:FSLR) stock fell 2.5% after Citigroup downgraded the solar panel manufacturer to ‘sell’ from ‘neutral’, citing uncertainty surrounding the company’s long-term outlook for margins and growth.
Kingsoft Cloud (NASDAQ:KC) stock fell 5.9% after Goldman Sachs downgraded the Chinese software company to ‘sell’ from ‘neutral’ with the stock up nearly 75% year to date.
Foghorn Therapeutics (NASDAQ:FHTX) stock fell around 22.9% after the FDA placed a partial clinical hold on the trial of the company’s key cancer drug.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.